ImmuRise
ImmuRise Biocontrol France is a French biotechnology company developing D Extract, a 100% natural biopesticide derived from Amphidinium carterae marine microalgae. It targets viticulture, field crop, and vegetable producers with foliar and seed treatments designed to replace synthetic pesticides.
- Company typePrivate
- Founded2016
- HeadquartersPessac, France
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What ImmuRise does
ImmuRise Biocontrol France (IBF) is a French biotechnology company founded in December 2016 in Pessac, Gironde (now headquartered in Cestas), that develops biocontrol solutions from marine micro-organisms to replace synthetic pesticides in agriculture. The company's core offering is D Extract (Extrait D), a 100% natural, residue-free antifungal biopesticide derived from the marine dinoflagellate Amphidinium carterae strain ICC001. IBF serves three vertical markets: viticulture (grapevine downy mildew), field crop and seed-producer customers (sorghum, corn, rice seed treatments), and vegetable producers (cabbage, potato late blight), with initial geographic focus on Nouvelle-Aquitaine and Bordeaux.
The underlying technology exploits natural molecules produced by A. carterae that bind ergosterol — a building block of fungal cell membranes — disrupting membrane integrity and eliminating fungal pathogens, with in vitro efficacy against approximately 80% of plant-pathogenic fungi. The platform is organized into three operational poles: a Sea Department maintaining a collection of 650 microalgae and marine bacteria strains (supplemented by a Tara Ocean expedition partnership), a Formulation Center adapting D Extract into foliar sprays and seed treatments, and an Earth Section validating photobioreactor (PBR) production under indoor and outdoor conditions after four years of cultivation trials. A UV-mutagenised A. carterae strain library is being screened to enhance bioactive compound yields.
IBF is pre-revenue, with planned European market launch in 2026 and industrial-scale PBR production targeted for 2027. Revenue will be generated through B2B sales of formulated biopesticides to farmers, vineyards, and seed companies via agricultural distribution channels. Two strategic investor-distributors are central to commercial access: De Sangosse, a regional biocontrol leader in Nouvelle-Aquitaine that led the €5M capital injection in 2023, and Baron Philippe de Rothschild (BPhR), the Bordeaux wine major providing viticulture market entry. International production partnerships with Algalíf Iceland (EUREKA Eurostars SOLA project, targeting hundreds of tonnes/year), İMBİYOTAB at Boğaziçi University (3,000-liter pilot scalable to 30,000 liters), and CarbonWorks (French domestic PBR production, a Fermentalg/SUEZ spinoff) underpin supply chain scaling.
ImmuRise firmographics
Firmographics- Name
- ImmuRise
- Legal name
- IMMUNRISE BIOCONTROL FRANCE
- Website
- https://immunrisebiocontrol.fr
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- ImmuRise Biocontrol France is a French biotechnology company developing D Extract, a 100% natural biopesticide derived from Amphidinium carterae marine microalgae. It targets viticulture, field crop, and vegetable producers with foliar and seed treatments designed to replace synthetic pesticides.
- Ownership category
- akta.pro rank
ImmuRise industry classification
Industry- Product category
- Agricultural Biocontrol / Biopesticides
- NAICS
- Pesticide and Other Agricultural Chemical Manufacturing (32532)
- akta.pro primary industry
- Biological Formulation, Fermentation & Scale-Up Manufacturing (AFABAEAM)
- akta.pro secondary industry
- Biological Seed Treatments & Inoculants (within Biologicals) (AFABAEAL)
Keywords
Where ImmuRise is headquartered
LocationHeadquarters
- HQ city
- Pessac
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
ImmuRise business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Revenue model
- Biopesticide Product Sales (Planned): Revenue will be generated from the sale of formulated biopesticide products based on D Extract, targeting both foliar applications and seed treatments. The company is developing a full product portfolio targeting viticulture (grapevine downy mildew), field crops (sorghum, corn), and vegetable crops (cabbage, potatoes). Products will be sold to farmers, vineyards, and through agricultural distribution channels. Market launch is planned for 2026 in Europe, with scale-up production planned for 2027.
- Seed Treatment Solutions (Planned): Specialized seed treatment products for protecting seeds against fungal diseases (e.g., Gibberella fujikuroi in sorghum, Alternaria brassicicola in cabbage). Revenue model based on product sales of seed treatment formulations to seed producers and farmers.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels4 records
ImmuRise product offering
Product offeringCore offering
ImmuRise (Immunrise Biocontrol France, IBF) develops and produces a 100% natural biopesticide called D Extract, derived from the marine microalgae Amphidinium carterae (strain ICC001). The active molecules are formulated into foliar sprays and seed treatments to protect vineyards, field crops, and vegetable crops from fungal pathogens. Market launch is planned for 2026 with industrial scale-up scheduled for 2027.
Product overview
Immunrise Biocontrol (IBF) is a single-product company built around D Extract (Extrait D), a 100% natural marine microalgae-based biopesticide derived from Amphidinium carterae. D Extract is the core active ingredient, formulated into two product lines: Foliar Treatment for leaf spray applications targeting fungal diseases such as grapevine downy mildew and potato late blight, and Seed Treatment for seed coating applications targeting seed-borne pathogens in field crops and vegetables. The company also provides access to its microalgae strain bank (650 strains) and formulation expertise as part of its research and development service model, with an industrial scale-up planned for 2027 ahead of market launch in Europe.
Differentiator
Problem solved
Functional benefit
Products and services
- D Extract (Extrait D) Biopesticide A 100% natural, residue-free antifungal biopesticide active ingredient derived from the marine microalgae Amphidinium carterae (strain ICC001). Effective against approximately 80% of plant-pathogenic fungi through affinity with ergosterol in fungal cell membranes. Commercial launch is planned for 2026.
- Foliar Treatment (Traitement Foliaire) A foliar spray formulation of D Extract designed to protect crops such as grapevines and potatoes from fungal diseases including downy mildew (Plasmopara viticola) and late blight (Phytophthora infestans). Trial-validated at 98% efficacy on grape clusters and 97% on leaves. Commercial launch is planned for 2026.
- Seed Treatment (Traitement de Semences) A seed coating formulation of D Extract for protecting field crop seeds (sorghum, corn) and vegetable seeds (cabbage, broccoli, cauliflower) from seed-borne fungal pathogens such as Gibberella fujikuroi and Alternaria brassicicola. Trial-validated at greater than 70% efficacy on sorghum and 90% efficacy on cabbage. Commercial launch is planned for 2026.
Quantifiable outcome
- 98% efficacy on grape clusters and 97% on leaves against grapevine downy mildew in 2025 field trials (Château Lambert), comparable to conventional treatment achieving 100%/86%
- +6 more outcomes
Companies that use ImmuRise
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
ImmuRise technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
ImmuRise partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core, supporting and minor.
- İMBİYOTAB (Boğaziçi University)coreInternational partnership with the İMBİYOTAB laboratory at Boğaziçi University (Istanbul), led by Prof. Berat Haznedaroğlu, for pilot production of 3,000 liters of microalgae culture (potentially reaching 30,000 liters). Objectives include producing microalgal biomass on an industrial demonstration scale using hybrid lighting systems, testing strain productivity in real industrial conditions, and feeding the bioactives pipeline for regulatory tests.
- Algalíf IcelandcoreSince 2023, IBF has been working with Algalíf Iceland to establish a long-term strategic partnership for developing a microalgae farm dedicated to producing microalgae on a large scale for the D extract biocontrol market. The aim is to produce several hundred tonnes per year. The EUREKA Eurostars 3 SOLA project (awarded July 2023) enables the IBF-Algalif consortium to begin industrial production, scale-up, and optimization in a pilot unit on the Icelandic site. Algalíf is a market leader in natural Astaxanthin production with a new facility in Reykjanesbaer, Iceland.
- CarbonWorks (Spinoff Fermentalg & SUEZ)coreCarbonWorks, an industrial biotechnology company specializing in autotrophic microalgae production, confirmed its ability to produce the ICC001 microalgae to IBF's specifications in a photobioreactor entirely designed and manufactured in France. The CarbonWorks technology is based on decarbonization of emitting sites, capturing CO2 for microalgae photosynthesis. IBF is awaiting the roll-out of a CarbonWorks industrial park in France for local raw material production.
- Tara Ocean FoundationsupportingAn expedition led by IBF's team in partnership with Tara Ocean Foundation's scientific teams to create a bank of marine microorganisms for identifying new bioactives. This collaboration supports the company's pipeline development of marine-derived biocontrol solutions.
- IBENS (Institut de Biologie de l'École Normale Supérieure, Paris)supportingImmunrise Biocontrol is an independent French company that stems from IBENS (Paris). The company was founded by a researcher and an agronomist from IBENS, and the institute remains a research partner for the company's scientific work.
- IFREMERsupportingIFREMER (Institut Français de Recherche pour l'Exploitation de la Mer) supports IBF's research in marine biology and microalgae science, leveraging expertise in marine microorganisms.
- ISVV (Institut des Sciences de la Vigne et du Vin)supportingISVV supports IBF's field trials and product development for viticulture applications, contributing technical expertise in vine health and wine production.
- Sorbonne Université (Institut de Biologie Physico-Chimique)supportingSorbonne Université supports IBF's research in marine biology, bringing expertise in physico-chemical biology to the company's microalgae-based biocontrol development.
- Roscoff Biological Station (CNRS/Sorbonne Université)supportingRoscoff Biological Station supports IBF's marine biology research and microalgae strain collection development, leveraging expertise in marine microorganisms from the Brittany coast.
- AUDACEminorAUDACE supports IBF as part of the company's network of agricultural professionals, scientific research, and industry partners for developing innovative solutions.
- DRAAF Nouvelle-AquitaineminorDRAAF (Direction Régionale de l'Alimentation, de l'Agriculture et de la Forêt) Nouvelle-Aquitaine is a regional agricultural authority supporting IBF's development and field trial activities.
- TutiacminorTutiac is a wine cooperative/vineyard group in Bordeaux that supports IBF's field trials and serves as a partner in testing and validating the biopesticide solution in real vineyard conditions.
- EABA (European Algal Biomass Association)minorIBF became a member of EABA at the end of 2022 and participates in the association's objective of promoting exchanges and collaboration in algal biomass production through its R&D work on microalgae. IBF presented at AlgaEurope 2023.
Scale indicators10 records
Recent moves6 records
Expansion highlights5 records
ImmuRise competitors and assessment
Company assessmentBroad incumbents
- Lallemand Plant Care: Lallemand Plant Care develops yeast- and bacteria-based biocontrol and biostimulant products for horticulture, viticulture, and broadacre crops. Directly comparable to IBF's microbial-based viticulture fungicide ambitions, with established European distribution and broader product portfolio.
- Koppert Biological Systems: Koppert is a global incumbent in biological crop protection with an established portfolio of microbial biopesticides, biostimulants, and beneficial organisms. Comparable to IBF as a biocontrol specialist, but with substantially broader product portfolio, global distribution, and scale across multiple modes of action.
- Novonesis (Novozymes) Agricultural Biologicals: Novonesis (formerly Novozymes) is the global market leader in industrial enzymes and microbial agricultural biologicals with a sizable biocontrol portfolio. Comparable to IBF as a microbial-based crop input developer, though operating at vastly larger scale and broader biological scope.
- Andermatt Group: Andermatt Group is a Swiss-based global biocontrol company with a broad portfolio of baculovirus-, bacteria-, and fungi-based products across multiple crops and geographies. Comparable to IBF as an established biocontrol pure-play with similar biological IP-driven approach.
Direct peers
- Agrauxine (Lesaffre): Agrauxine is Lesaffre's biocontrol subsidiary developing yeast-, fungi-, and bacteria-based crop protection products for foliar, seed treatment, and soil applications. Directly comparable to IBF as a French-headquartered microbial biopesticide player targeting similar European row crop and specialty crop segments.
- Bioline AgroSciences: Bioline AgroSciences produces invertebrate and microbial biocontrol agents for protected crops and arable farming, with strong European distribution. Directly comparable to IBF as a specialized biocontrol company, though its portfolio is biased toward beneficial insects and macrobials rather than microalgae-based fungicides.
- M2i Life Sciences: M2i Life Sciences is a French ag-biotech producing pheromone- and biological-based crop protection products for European specialty and field crops. Comparable to IBF as a French-headquartered biocontrol pure-play with European regulatory pathway and similar end customer segments.
- De Sangosse: De Sangosse is a French leader in biocontrol solutions and IBF's anchor investor and distribution partner. They operate a broad portfolio of biocontrol and adjuvant products directly overlapping with IBF's viticulture and field crop ambitions, and are also a potential customer/channel rather than purely a competitor.
Emerging players
- Symborg: Symborg is a Spanish ag-biotech specializing in microbial inoculants and biocontrol products for specialty crops, now part of Corteva's biologicals portfolio. Comparable to IBF as a microbial-based crop protection specialist with European viticulture exposure, though with broader crop and input coverage.
- Biotalys: Biotalys is a Belgian ag-biotech developing protein-based biocontrols (e.g., Evoca) targeting fungal and bacterial diseases in fruits and vegetables. Comparable to IBF as a venture-backed pre-commercial biocontrol innovator targeting similar disease control use cases with novel biological modes of action.
Market position
Strengths1 record
Weaknesses5 records
Competitive moat5 records
Customer concentration
ImmuRise social profiles
Digital presenceImmuRise financial estimates
Financial estimateRevenue estimate
Valuation estimate
ImmuRise leadership team
Management profileNumber of profiles
Profiles9 records
ImmuRise funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ImmuRise M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ImmuRise
What does ImmuRise do?
ImmuRise (Immunrise Biocontrol France, IBF) develops and produces a 100% natural biopesticide called D Extract, derived from the marine microalgae Amphidinium carterae (strain ICC001). The active molecules are formulated into foliar sprays and seed treatments to protect vineyards, field crops, and vegetable crops from fungal pathogens. Market launch is planned for 2026 with industrial scale-up scheduled for 2027.
Is ImmuRise a public or private company?
ImmuRise is a private company. It is classified as venture growth investor backed and is currently operating.
When was ImmuRise founded?
ImmuRise was founded in 2016. It employs 1 to 10 people.
Where is ImmuRise based?
ImmuRise is headquartered in Pessac, France, in the Europe region.
How does ImmuRise make money?
Two revenue lines are on record. Biopesticide Product Sales (Planned) is the primary driver. The others are seed Treatment Solutions (Planned).
Who are ImmuRise's main competitors?
Broad incumbents on record are Lallemand Plant Care, Koppert Biological Systems, Novonesis (Novozymes) Agricultural Biologicals and Andermatt Group. Direct peers are Agrauxine (Lesaffre), Bioline AgroSciences, M2i Life Sciences and De Sangosse. Emerging players are Symborg and Biotalys.
Does ImmuRise have an API?
No public API is recorded for ImmuRise.
What industry is ImmuRise in?
ImmuRise's product category is Agricultural Biocontrol / Biopesticides. Its primary akta.pro industry code is AFABAEAM, Biological Formulation, Fermentation & Scale-Up Manufacturing, with a secondary code of AFABAEAL, Biological Seed Treatments & Inoculants (within Biologicals). Its NAICS code is 32532.